Cargando…
Implementation and Safety of a Single Fraction Peripheral Lung SBRT during the Global COVID-19 Pandemic, a Single Institution's Experience
PURPOSE/OBJECTIVE(S): In response to the COVID-19 pandemic, a single fraction peripheral lung SBRT program was established to minimize potential COVID-19 exposures. This analysis aims to review clinical and treatment characteristics and associated toxicities in appropriately selected patients for th...
Autores principales: | Alfaifi, S., Kim, J., Rathod, S., Hunter, W., Leylek, A., Ahmed, N., Venkataraman, S., Venugopal, N., Kane, B., Chowdhury, A.D., Dubey, A., Sivananthan, G., Kakumanu, S.A., Bashir, B.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595454/ http://dx.doi.org/10.1016/j.ijrobp.2022.07.1480 |
Ejemplares similares
-
31: Single Fraction Peripheral Lung SBRT During the Global COVID-19 Pandemic at a Cancercare Manitoba: An Analysis of Technical Feasibility and Clinical Safety
por: Alfaifi, Salem, et al.
Publicado: (2022) -
Bracing for impact with new 4R’s in the COVID-19 pandemic – A provincial thoracic radiation oncology consensus()
por: Rathod, Shrinivas, et al.
Publicado: (2020) -
Clinical Characteristics and Prognosis of Primary Tracheal Cancer: A Single Institution Experience
por: Koul, Rashmi, et al.
Publicado: (2018) -
Clinical Outcomes After Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer: A Single Institutional Study
por: Abdalmassih, Michael, et al.
Publicado: (2020) -
Impact of Pre-Treatment NLR and Other Hematologic Biomarkers on the Outcomes of Early-Stage Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
por: AduQuaye, Marina, et al.
Publicado: (2022)